Literature DB >> 17161238

Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Robert H Pietrzak1, Catherine M Mollica, Paul Maruff, Peter J Snyder.   

Abstract

A growing body of literature has examined the cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD). However, a clear understanding of the types and magnitude of such effects are difficult to discern from such a large and varied collection of published reports. This review evaluated a total of 40 relevant placebo-controlled studies published since Rapport and Kelly's [1993. Psychostimulant effects on learning and cognitive function. In: Matson, J.L. (Ed.), Handbook of Hyperactivity in Children. Allyn & Bacon, Boston, pp. 97-136] original review of cognitive effects of methylphenidate in children with ADHD. Of these published studies, 63.5% identified some improvement in cognitive function following methylphenidate treatment. Methylphenidate improved performance on saccadic eye movement, planning/cognitive flexibility, attention/vigilance, and inhibitory control tasks in 83.3%, 71.4%, 70.6%, and 69.7% of studies, respectively. A total 58.3% and 50% of studies that evaluated the effect of methylphenidate on tasks of memory and working memory/divided attention, respectively, noted improvement. Variability of findings across studies may be explained by differential effects of methylphenidate on brain function, intra- and inter-individual variability in medication response, methodological limitations, and problems associated with repeated neuropsychological assessment and metric properties of commonly utilised neuropsychological instruments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161238     DOI: 10.1016/j.neubiorev.2006.10.002

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  70 in total

1.  Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers.

Authors:  A M W Linssen; E F P M Vuurman; A Sambeth; W J Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-12-15       Impact factor: 4.530

2.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Heather M Conklin; Susan Helton; Jason Ashford; Raymond K Mulhern; Wilburn E Reddick; Ronald Brown; Melanie Bonner; Bruce W Jasper; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  J Pediatr Psychol       Date:  2009-05-22

Review 3.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

4.  Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Authors:  Tanya E Froehlich; Jason Fogler; William J Barbaresi; Nada A Elsayed; Steven W Evans; Eugenia Chan
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

Review 5.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

6.  Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions.

Authors:  Sarah V Spencer; Larry W Hawk; Jerry B Richards; Keri Shiels; William E Pelham; James G Waxmonsky
Journal:  J Abnorm Child Psychol       Date:  2009-08

7.  Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects.

Authors:  Emily Carias; Dennis Fricke; Abisha Vijayashanthar; Lauren Smith; Rathini Somanesan; Connor Martin; Leanna Kalinowski; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  Behav Brain Res       Date:  2018-08-24       Impact factor: 3.332

8.  Relationship Between Executive Functioning and Symptoms of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in 6-8 Year Old Children.

Authors:  Rachel Jane Neely; Jessica Leigh Green; Emma Sciberras; Philip Hazell; Vicki Anderson
Journal:  J Autism Dev Disord       Date:  2016-10

9.  Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.

Authors:  James T McCracken; James J McGough; Sandra K Loo; Jennifer Levitt; Melissa Del'Homme; Jennifer Cowen; Alexandra Sturm; Fiona Whelan; Gerhard Hellemann; Catherine Sugar; Robert M Bilder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-06-03       Impact factor: 8.829

Review 10.  Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Authors:  Marisa E Marraccini; Lisa L Weyandt; Joseph S Rossi; Bergljot Gyda Gudmundsdottir
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.